Targeted Drug Delivery Systems for Treating Gastrointestinal Inflammatory Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: closed (10 November 2021) | Viewed by 4411
Special Issue Editor
Interests: nanomedicine; colon-targeted delivery; wound healing; nitric oxide delivery; infectious diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
The gastrointestinal tract (GIT), which includes all the digestive systems extending from the mouth to the anus, is often vulnerable to inflammation. Gastrointestinal inflammatory diseases including periodontitis, gastric ulcer, gastritis, Crohn’s disease, and ulcerative colitis are significant sources of disease-associated morbidity and mortality as well as pain and disability worldwide. However, most of the drugs which are currently used to treat gastrointestinal inflammatory diseases do not selectively target the region where inflammation occurs, thus leading to frequent dosing and potential adverse effects which can negatively affect patient compliance. In this sense, there is an urgent need for innovative delivery systems that deliver a drug to the site of inflammation, prolong local drug availability, improve therapeutic efficacy, and reduce drug side effects.
This Special Issue of Pharmaceutics highlights the recent progress of targeted delivery systems that can effectively treat gastrointestinal inflammatory diseases. Any innovative systems that deliver a therapeutic agent to inflammatory regions in the GIT will be welcome.
Prof. Dr. Jin-Wook Yoo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gastrointestinal inflammation
- targeted delivery systems
- Crohn’s disease
- ulcerative colitis
- gastric ulcer
- gastritis
- periodontitis
